Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2014
10/02/2014US20140296201 Inhibitors of influenza viruses replication
10/02/2014US20140295437 Cyanine compounds and their application as quenching compounds
10/02/2014US20140294805 Novel compounds and compositions for the inhibition of nampt
10/01/2014EP2784073A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2784072A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2784071A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2784070A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2782914A1 Method for producing substituted 5-fluoro-1h-pyrazolopyridines
10/01/2014EP2782910A1 Process for preparing n-substituted 1h-pyrazole-5-carboxylate compounds and derivatives thereof
10/01/2014EP2782571A1 Heterocyclic compounds and uses thereof
09/2014
09/30/2014US8846947 Benzimidazoles and related analogs as sirtuin modulators
09/30/2014US8846931 Bipyridyl derivatives
09/30/2014US8846928 Benzamides and nicotinamides as Syk modulators
09/30/2014US8846925 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
09/30/2014US8846924 Sulfonamide derivatives of polycyclic dyes used for analytical applications
09/30/2014US8846923 Preparation of 14-hydroxycodeinone sulfate
09/30/2014US8846916 Sitagliptin synthesis
09/30/2014US8846914 Compositions to effect neuronal growth
09/30/2014US8846913 Neprilysin inhibitors
09/30/2014US8846907 Spiro-condensed indoline derivatives as pesticides
09/30/2014US8846712 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
09/30/2014US8846711 Heterocyclic acrylamides and their use as pharmaceuticals
09/30/2014US8846710 Method of preferentially inducing the biosynthesis of interferon
09/30/2014US8846709 7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1H-imidazo[4,5-C]quinoline derivatives
09/30/2014US8846702 Pyranyl aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
09/30/2014US8846694 Pyrrolidone derivatives for use as MetAP-2 inhibitors
09/30/2014US8846684 Arbovirus inhibitors and uses thereof
09/30/2014US8846673 Azaindazoles as kinase inhibitors and use thereof
09/30/2014US8846672 Imidazopyridines as respiratory syncytial virus antiviral agents
09/30/2014US8846664 Pyrazinopyrazines and derivatives as kinase inhibitors
09/30/2014US8846663 Modulators of 5-HT receptors and methods of use thereof
09/30/2014US8846661 Diazahomoadamantane derivatives and methods of use thereof
09/30/2014US8846658 Oxazine derivatives and their use in the treatment of neurological disorders
09/30/2014US8846657 Substituted imidazopyridines as HDM2 inhibitors
09/30/2014US8846656 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
09/25/2014WO2014153227A1 Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting nox-1
09/25/2014WO2014153214A1 Arginine methyl transferase inhibtors and uses thereof
09/25/2014WO2014153203A2 Alkyl-amine harmine derivatives for promoting bone growth
09/25/2014WO2014152621A1 P2x7 modulators
09/25/2014WO2014152604A1 P2x7 modulators
09/25/2014WO2014152589A1 P2x7 modulators
09/25/2014WO2014152588A1 Covalent inhibitors of kras g12c
09/25/2014WO2014151900A1 Protein kinase c inhibitors and uses thereof
09/25/2014WO2014151729A1 Compounds and compositions for the treatment of parasitic diseases
09/25/2014WO2014151444A1 Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
09/25/2014WO2014151411A1 Methods for treating inflammation, autoimmune disorders and pain
09/25/2014WO2014151409A1 Organic compounds
09/25/2014WO2014150289A1 Compounds and uses thereof for the modulation of hemoglobin
09/25/2014WO2014150132A1 Inhibitors of the renal outer medullary potassium channel
09/25/2014WO2014148053A1 Use of ep4 receptor antagonists in the treatment of cartilage disease
09/25/2014WO2014147203A1 3-heteroaryl substituted indazoles
09/25/2014WO2014146494A1 Β-aminocarbonyl compound, preparation method, pharmaceutical composition and use thereof
09/25/2014WO2014146492A1 N-(2-cyano heterocyclyl)pyrazolo pyridones as janus kinase inhibitors
09/25/2014WO2014146491A1 Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors
09/25/2014WO2014146249A1 Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors
09/25/2014WO2014146246A1 Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors
09/25/2014US20140288347 Compounds useful as inhibitors of atr kinase
09/25/2014US20140288308 Novel processes for the manufacture of propane-1-sulfonic acid -amide
09/25/2014US20140288307 Crystalline cis-(E)-4-(3-Fluorophenyl)-2',3',4',9'-tetrahydro-N,N-dimethyl-2'-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1'[1H]-pyrido[3,4-b]indol]-4-amine
09/25/2014US20140288303 Process for preparing methyl methylcarbamate and its purification for use as pharmaceutically active compound
09/25/2014US20140288133 3 -amino- pyrazole derivatives useful against tuberculosis
09/25/2014US20140288111 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
09/25/2014US20140288109 Mk2 inhibitors
09/25/2014US20140288105 Arginine methyltransferase inhibitors and uses thereof
09/25/2014US20140288095 Pyridopyrimidinone inhibitors of viruses
09/25/2014US20140288094 Pyrazolopyridyl compounds as aldosterone synthase inhibitors
09/25/2014US20140288084 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1
09/25/2014US20140288082 Bicyclic Heteroaryl Compounds
09/25/2014US20140288072 5 - benzylaminomethyl - 6 - aminopyrazolo [3, 4 -b] pyridine derivatives as cholesteryl ester-transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis
09/25/2014US20140288070 Compounds and methods for kinase modulation, and indications therefor
09/25/2014US20140288068 Alkyl-amine harmine derivatives for promoting bone growth
09/25/2014US20140288067 Carm1 inhibitors and uses thereof
09/25/2014US20140288064 Nitrogen containing heterocyclic compounds
09/25/2014US20140288062 Heteroaryl compounds and methods of use thereof
09/25/2014US20140288053 Anticancer pyridopyrazines via the inhibition of fgfr kinases
09/25/2014US20140288051 Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
09/25/2014US20140288050 Modulators of opioid receptors and methods of use thereof
09/25/2014US20140288049 2-Thiopyrimidinones
09/25/2014US20140288048 Heterocyclic compounds and uses thereof
09/25/2014US20140288043 Pyrazolopyridine compounds
09/25/2014US20140288042 Inhibitors of the renal outer medullary potassium channel
09/25/2014US20140287028 Use of Chemotherapeutic Agents
09/25/2014US20140286988 Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
09/25/2014US20140286970 Pyrrolobenzodiazepines and targeted conjugates
09/25/2014US20140286899 Inhibitors of hepatitis c virus
09/24/2014EP2781520A1 Three-ring pi3k and/or mtor inhibitor
09/24/2014EP2781519A1 Novel antiviral pyrrolopyridine derivative and a production method for same
09/24/2014EP2781518A2 Fluorine-containing 5-[2-(pyrid-3-yl)-ethyl]-2,3,4-tetrahydro-1h-pyrido[4,3-b]indoles as agents for reducing uncontrolled protein aggregation
09/24/2014EP2781508A1 Nitrogen-containing fused ring compounds for use as crth2 antagonists
09/24/2014EP2780342A1 Aminoquinazoline derivatives and their salts and methods of use
09/24/2014EP2780340A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides iii
09/24/2014EP2780332A1 Morpholinyl benzotriazine for use in cancer therapy
09/24/2014EP2780324A1 Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a
09/23/2014US8841462 Bicyclic heterocycles as MEK kinase inhibitors
09/23/2014US8841456 1,5-naphthyridine derivative or salt thereof
09/23/2014US8841454 Functionalized carbon nanostructures which are soluble in hydrocarbons and method for preparation
09/23/2014US8841448 Fluoroergoline analogs
09/23/2014US8841336 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
09/23/2014US8841331 Inhibitors of human immunodeficiency virus replication
09/23/2014US8841318 Substituted heterocycles as janus kinase inhibitors
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 646